Azopt and Conjunctivitis exacerbated - a phase IV clinical study of FDA data

Summary:

Conjunctivitis exacerbated is reported as a side effect among people who take Azopt (brinzolamide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Travatan, and have Intraocular pressure increased.

The phase IV clinical study analyzes which people have Conjunctivitis exacerbated when taking Azopt. It is created by eHealthMe based on reports of 7,917 people who have side effects when taking Azopt from the FDA, and is updated regularly.

What is Azopt?

Azopt has active ingredients of brinzolamide. It is often used in glaucoma. eHealthMe is studying from 8,058 Azopt users. Check the latest studies of Azopt.

What is Conjunctivitis exacerbated?

Conjunctivitis exacerbated (bad situation of conjunctivitis) is found to be associated with 1,067 drugs and 426 conditions by eHealthMe. Check the latest studies of Conjunctivitis exacerbated.

On Jul, 13, 2026

7,917 people reported to have side effects when taking Azopt.
Among them, 22 people (0.28%) have Conjunctivitis exacerbated.

Could Azopt cause Conjunctivitis exacerbated?

Among these 22 people:

How long have people been on Azopt when they have Conjunctivitis exacerbated? *

What is the gender of people who have Conjunctivitis exacerbated when taking Azopt? *

female: 52.38 %
male: 47.62 %

What is the age of people who have Conjunctivitis exacerbated when taking Azopt? *

What are other drugs people take besides Azopt? *

What are other side effects people have besides Conjunctivitis exacerbated? *

Ocular Hyperaemia (an abnormally large amount of blood in eye): 7 people, 31.82%
Eye Pruritus (eye itching): 6 people, 27.27%
Eye Irritation: 5 people, 22.73%
Corneal Opacity (scarring or clouding of the cornea): 4 people, 18.18%
Corneal Oedema (corneal swelling): 4 people, 18.18%
Visual Impairment: 3 people, 13.64%
Punctate Keratitis (inflammation of the cornea with tiny spots): 3 people, 13.64%
Eye Pain: 3 people, 13.64%
Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 2 people, 9.09%
Corneal Erosion (failure of the cornea's outermost layer of epithelial cells to attach to the underlying): 2 people, 9.09%

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 2 people, 9.09%
Intraocular Pressure Increased: 2 people, 9.09%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 4.55%
Intraocular Pressure Test Abnormal: 1 person, 4.55%
Hiv Infection: 1 person, 4.55%
High Blood Pressure: 1 person, 4.55%
Dry Eyes (lack of adequate tears): 1 person, 4.55%
Diabetes: 1 person, 4.55%
Cystoid Macular Oedema (fluid accumulation after cataract surgery): 1 person, 4.55%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Azopt and have Conjunctivitis exacerbated?

- Check whether Conjunctivitis exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azopt:

Azopt (8,058 reports)

Browse all side effects of Azopt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (1,067 drugs)

Browse all the conditions that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (426 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on brinzolamide (the active ingredients of Azopt) and Azopt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.